An App (EUS) dedicated to endoscopic ultrasound education has been developed by Drs Shyam Varadarajulu, Paul Fockens and Robert Hawes. This App is a must-have for all endoscopists, pulmonologists and gastroenterology/pulmonology trainees interested in EUS. Future developments will include sections dedicated to Endobronchial Ultrasound (EBUS) and Updated videos and literature review.

EUS - Diagnostic and Interventional Endoscopic Ultrasound alternatives

CHEST Journal App

It just got a whole lot easier to keep up with the most recent and compelling information in the multidisciplinary specialties of chest medicine. Each month, the journal CHEST features the best in peer-reviewed, cutting-edge original research and evidence-based medicine guidelines and consensus statements in pulmonary, critical care, and sleep medicine. Our privacy policy is here: http://www.elsevier.com/EULA_Apple_apps

  • size 51.3 MB

Gastrointestinal Endoscopy

Gastrointestinal EndoscopyNow its easy to keep up with the most important advances in the study, diagnosis and treatment of digestive diseases. The Gastrointestinal Endoscopy app brings you the convenience of reading your favorite journal from anywhere in the world with just a tap. Our privacy policy is here: http://www.elsevier.com/EULA_Apple_apps

MELD Calculator

This MELD Calculator is specifically for the liver transplant physician. This version now includes the the MELD-Na result that is being used to allocate livers since January 2016.It is an educational tool and should not be used for patient care.

  • size 7.0 MB

AGA-DDSEP7

Enhance your knowledge of GI medicine with case-based questions to test your recall, interpretation and problem-solving skills at $5.99/chapter. Or purchase all 16 chapters for $89.99. DDSEPs flexible format is also ideal for obtaining continuing medical education credits conveniently and efficiently.

  • size 40.5 MB

HCV Treatment Path

This app provides up-to-date HCV treatment guidelines for health care practitioners, based on information from the American Association for the Study of Liver Diseases (AASLD) and other credible, scientific sources. Numerous new direct-acting oral medications to treat chronic hepatitis C infections have been approved over the past few years, with several approved in just the past few months. Treatment guidelines have been under near-constant revision with these new therapies.

  • size 73.1 MB